Scientists at Tel Aviv University develop new gene therapy for deafness | JNS
A new study from Tel Aviv University (TAU) presents an innovative treatment for deafness based on the delivery of genetic material into the cells of the inner ear. The genetic material “replaces” the genetic defect and enables the cells to continue functioning normally.
The scientists were able to prevent the gradual deterioration of hearing in mice that had a genetic mutation for deafness. They maintain that this novel therapy could lead to a breakthrough in treating children born with various mutations that eventually cause deafness.